SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company’s Continued Listing on the Nasdaq Capital Market
Rhea-AI Summary
SCWorx (Nasdaq: WORX) announced that it received a partial compliance letter from the Nasdaq Hearings Panel, confirming completion of the first benchmark in its plan to regain full compliance for continued listing on the Nasdaq Capital Market. Under the Panel’s decision, SCWorx must still achieve a minimum closing bid price of $1.00 per share for at least 20 consecutive trading days, as required by Nasdaq Listing Rule 5815(c)(4). The company must promptly inform Nasdaq of any material changes to its compliance plan or circumstances affecting its ability to meet the exception’s conditions, and the Panel has reserved the right to reconsider the exception terms. SCWorx’s CEO stated that maintaining the Nasdaq listing is a strategic priority and that the company intends to take all actions necessary to satisfy the Panel’s conditions and update investors on its progress.
Positive
- Nasdaq Panel confirms first benchmark completed in compliance plan
- Company retains continued listing path via granted compliance exception
- Management reiterates strategic priority of maintaining Nasdaq listing
Negative
- Must achieve $1.00 minimum bid for 20 consecutive trading days
- Panel may reconsider exception if adverse developments occur
- Ongoing obligation to report material changes that could affect compliance
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 08 | AI deployment | Positive | +0.5% | Announced deployment of an AI-assisted healthcare supply chain data management model. |
| Jun 23 | Nasdaq listing decision | Positive | +115.5% | Nasdaq panel allowed continued listing subject to specified compliance conditions. |
| Apr 22 | Customer wins | Positive | +1.2% | Announced two new customer engagements through a strategic partner channel. |
| Mar 04 | SaaS customer agreement | Positive | -24.8% | Signed a healthcare provider customer agreement supporting Workday implementation and ERP optimization. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Three of four recent positive announcements aligned with positive 24-hour reactions, while one positive customer announcement diverged.
Key Terms
data normalization technical
minimum bid price requirement regulatory
closing bid price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIDDLETON, MA, July 29, 2026 (GLOBE NEWSWIRE) -- SCWorx Corp. ("SCWorx" or the "Company"), a provider of data normalization and supply chain solutions for the healthcare industry, today announced that it has received a partial compliance letter from the Nasdaq Hearings Panel (the "Panel") confirming completion of the first benchmark for the Company’s approved plan to regain compliance for continued listing on The Nasdaq Capital Market.
Under the terms of the Panel's previous decision, SCWorx must demonstrate compliance with Nasdaq's minimum bid price requirement by achieving a closing bid price of at least
The company must still immediately notify Nasdaq of any material changes to its compliance plan or any event, condition, or circumstance that could affect the Company's ability to satisfy the requirements of the exception granted previously. The Panel also reserved the right to reconsider the terms of the exception should any developments arise that, in the Panel's judgment, make continued listing of the Company's securities inadvisable or unwarranted.
"We appreciate the Panel's continued consideration and for the opportunity to continue our Nasdaq listing while we execute the next phases of our compliance plan," said Tim Hannibal, President and Chief Executive Officer of SCWorx. "Maintaining our Nasdaq listing remains a strategic priority as we continue to focus on expanding customer relationships, advancing our healthcare supply chain data management platform, and creating long-term value for shareholders."
The Company intends to take all actions necessary to satisfy the conditions established by the Panel and will continue to keep investors informed regarding its progress.
About SCWorx Corp.
SCWorx is a provider of data management and analytics solutions focused on improving operational efficiency, data accuracy, and cost savings for healthcare organizations. The Company’s platform enables the normalization, aggregation, and analysis of complex data sets to support supply chain optimization, financial performance, and regulatory compliance.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. SCWorx undertakes no obligation to update any forward-looking statements except as required by law.
Investor Relations Contact:
SCWorx Investor Relations